em 139 has been researched along with 9,10-dimethyl-1,2-benzanthracene in 1 studies
| Studies (em 139) | Trials (em 139) | Recent Studies (post-2010) (em 139) | Studies (9,10-dimethyl-1,2-benzanthracene) | Trials (9,10-dimethyl-1,2-benzanthracene) | Recent Studies (post-2010) (9,10-dimethyl-1,2-benzanthracene) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 6,010 | 10 | 772 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Labrie, C; Labrie, F; Lévesque, C; Li, S; Mérand, Y | 1 |
1 other study(ies) available for em 139 and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
Topics: 17-Hydroxysteroid Dehydrogenases; 9,10-Dimethyl-1,2-benzanthracene; Animals; Estradiol; Estrogen Antagonists; Estrone; Female; Mammary Neoplasms, Experimental; Rats; Rats, Sprague-Dawley | 1995 |